US Stock MarketDetailed Quotes

SPRY ARS Pharmaceuticals

Watchlist
  • 10.670
  • +0.130+1.23%
Trading Jul 22 15:08 ET
1.03BMarket Cap-20519P/E (TTM)

ARS Pharmaceuticals Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

ARS Pharmaceuticals Earnings Date

Currency: USD

Period

Q1 FY2024 Earnings

--

Revenue(YoY)

0.00

-100.00%
EPS(YoY)

-0.11

+31.25%
Analyst Rating

Buy

Jul 22, 2024

ARS Pharmaceuticals Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 2 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: USD

Actual
Estimate
DatePeriodRevenue/EstimateEarnings Call
--2024/Q3-- / 1.000M--
--2024/Q2-- / 1.000M--
--2024/Q10.000 / 0.000--
--2023/Q40.000 / 0.000--
--2023/Q30.000 / 0.000--
DatePeriodRevenue/EstimateEarnings Call
--2024/Q3-- / 1.000M--
--2024/Q2-- / 1.000M--
--2024/Q10.000 / 0.000--
--2023/Q40.000 / 0.000--
--2023/Q30.000 / 0.000--

Unlock Free Earnings Estimates

ARS Pharmaceuticals Earnings Reports

  • ARS Pharmaceuticals | 10-Q: Quarterly report

    May 9 16:22 ET

  • ARS Pharmaceuticals | 10-K: Annual report

    Mar 21 22:22 ET

  • ARS Pharmaceuticals | 10-Q: Quarterly report

    Nov 9, 2023 16:04 ET

  • ARS Pharmaceuticals | 10-Q: Q2 2023 Earnings Report

    Aug 10, 2023 16:08 ET

    • Read more

    Analysis

    Analyst Rating

    Updated: Jul 22, 2024

    Buy

    • Buy

      100.00%

    • Hold

      0.00%

    • Sell

      0.00%

    Price Target

    No Data

    Heat List
    US
    Overall
    Symbol
    Latest Price
    %Chg